Teaching agentic AI to generalize expert diagnostic reasoning in rare diseases
On the map: LLM reasoning → Clinical and biomedical applications
also in 1 more
Abstract (arXiv)
Rare disease diagnosis depends on expert reasoning that is scarce and difficult to transfer. Large language models rank the correct disease first in only 35.4% of benchmark cases and often rely on learned phenotype-disease associations rather than reusable diagnostic reasoning strategies. We developed liteOdyssey through Policy Iteration with Human Feedback, a process in which model failures and expert corrections are iteratively consolidated into a clinician-gated, natural-language policy executed by a language model. Across 1,243 public benchmark cases spanning 722 rare diseases, liteOdyssey ranked the correct disease first in 59.3% of cases versus 26.5% without the policy, with comparable gains in cases involving diseases excluded from policy development. The same policy transferred across model families and sizes without retraining. Adaptation of the policy to the Undiagnosed Diseases Network (UDN) improved diagnostic accuracy among 515 UDN patients, with gains confirmed by blinded physician adjudication. These results show that expert reasoning can be externalized into an inspectable and revisable natural-language policy that generalizes across rare diseases, transfers across model backbones, and adapts to a real-world patient cohort.
Key facts. Cited by 1 paper in the map (data through 14 Oct 2026). Placed in Clinical and biomedical applications, one of 17 directions in LLM reasoning. Builds on 19 of its 45 references that are in the map. First posted on arXiv 15 Jun 2026.
Builds on
19 of 45 references.
Closest ancestors · 2
Same direction, newest first
- 2025A Specialized Large Language Model for Clinical Reasoning and Diagnosis in Rare Diseases18 Nov
- 2025End-to-End Agentic RAG System Training for Traceable Diagnostic Reasoning21 Aug
Other references · 17
- 2020Language Models are Few-Shot Learnerscited by 32,419
- 2020Scaling Laws for Neural Language Modelscited by 6,586
- 2023Reflexion: Language Agents with Verbal Reinforcement Learningcited by 4,276
- 2017Deep reinforcement learning from human preferencescited by 3,912
- 2022Training Compute-Optimal Large Language Modelscited by 3,019
- 2019Fine-Tuning Language Models from Human Preferencescited by 2,150
- 2026DeepSeek-V4: Towards Highly Efficient Million-Token Context Intelligencecited by 1,040
- 2024LLM Evaluators Recognize and Favor Their Own Generationscited by 686
- 2025GEPA: Reflective Prompt Evolution Can Outperform Reinforcement Learningcited by 542
- 2026SkillsBench: Benchmarking How Well Agent Skills Work Across Diverse Taskscited by 315
- 2025Inference-Time Scaling for Generalist Reward Modelingcited by 239
- 2026On-Policy Context Distillation for Language Modelscited by 186
5 more
- 2024MDAgents: An Adaptive Collaboration of LLMs for Medical Decision-Makingcited by 163
- 2022Learning by Distilling Contextcited by 138
- 2026How Well Do Agentic Skills Work in the Wild: Benchmarking LLM Skill Usage in Realistic Settingscited by 65
- 2026Doc-to-LoRA: Learning to Instantly Internalize Contextscited by 43
- 2025Reward Is Enough: LLMs Are In-Context Reinforcement Learnerscited by 31
Built on by
Citing papers per year: 2026: 1.
1 paper.
Similar, not cited
Close in wording, no citation either way
- 2026RareDxR1: Autonomous Medical Reasoning for Rare Disease Diagnosis Beyond Human Annotation
- 2026RareLens: Towards End-to-End Rare Disease Care via Aligning Divergent Large Language Model Reasoning
- 2025An Agentic System for Rare Disease Diagnosis with Traceable Reasoning
- 2026A specialized reasoning large language model for accelerating rare disease diagnosis: a randomized AI physician assistance trial
- 2026TrustMed-RL: Long-Horizon Reinforcement Learning for Evidence-Grounded Clinical Diagnosis
- 2025Learning to reason about rare diseases through retrieval-augmented agents
- 2026Evaluating Multi-Agent LLM Architectures for Rare Disease Diagnosis
- 2026RareAlert: Aligning heterogeneous large language model reasoning for early rare disease risk screening